Published in J Gen Intern Med on March 12, 2008
Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria. Diabetes Care (2010) 3.12
Distribution of hyperglycaemia and related cardiovascular disease risk factors in low-income countries: a cross-sectional population-based survey in rural Uganda. Int J Epidemiol (2010) 2.52
Evaluation of nonfasting tests to screen for childhood and adolescent dysglycemia. Diabetes Care (2011) 1.14
Metabolic health reduces risk of obesity-related cancer in framingham study adults. Cancer Epidemiol Biomarkers Prev (2014) 0.92
Diabetes care in black and white veterans in the southeastern U.S. Diabetes Care (2010) 0.89
Blood spot-based measures of glucose homeostasis and diabetes prevalence in a nationally representative population of young US adults. Ann Epidemiol (2014) 0.86
Incidental findings of elevated random plasma glucose in the ED as a prompt for outpatient diabetes screening: a retrospective study. BMJ Open (2013) 0.77
Random blood glucose: a robust risk factor for type 2 diabetes. J Clin Endocrinol Metab (2015) 0.77
Performance of a Random Glucose Case-Finding Strategy to Detect Undiagnosed Diabetes. Am J Prev Med (2017) 0.75
Delay in diagnosis of diabetes is not the patient's fault. Diabetes Care (2010) 0.75
Pre-diagnosis blood glucose and prognosis in women with breast cancer. Cancer Metab (2016) 0.75
Systematic Review and Meta-Analysis of Response Rates and Diagnostic Yield of Screening for Type 2 Diabetes and Those at High Risk of Diabetes. PLoS One (2015) 0.75
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79
Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care (1998) 18.69
Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes (2003) 16.62
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet (2006) 15.32
Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA (2004) 12.13
Clinical inertia. Ann Intern Med (2001) 11.14
Lifetime risk for diabetes mellitus in the United States. JAMA (2003) 10.33
Economic costs of diabetes in the US in 2002. Diabetes Care (2003) 8.92
The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care (2003) 7.74
Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care (1992) 7.69
Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med (2006) 7.32
The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med (2005) 6.63
Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care (2006) 5.25
Diagnosis and classification of diabetes mellitus. Diabetes Care (2005) 4.47
An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes. Diabetes Care (2007) 4.14
The cost-effectiveness of screening for type 2 diabetes. CDC Diabetes Cost-Effectiveness Study Group, Centers for Disease Control and Prevention. JAMA (1998) 3.24
Screening for type 2 diabetes mellitus: a cost-effectiveness analysis. Ann Intern Med (2004) 3.06
United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol (1998) 2.93
Diabetes in America: epidemiology and scope of the problem. Diabetes Care (1998) 2.68
A Danish diabetes risk score for targeted screening: the Inter99 study. Diabetes Care (2004) 2.65
Prevalence of diabetes and impaired fasting glucose in adults--United States, 1999-2000. MMWR Morb Mortal Wkly Rep (2003) 2.60
The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study. Diabetes (2006) 2.40
A risk score for predicting incident diabetes in the Thai population. Diabetes Care (2006) 2.21
Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care (2002) 2.16
Exercise testing and electron beam computed tomography in the evaluation of coronary artery disease. J Am Coll Cardiol (2000) 2.15
Diabetes detection in Australian general practice: a comparison of diagnostic criteria. Med J Aust (2002) 2.14
The prevention or delay of type 2 diabetes. Diabetes Care (2002) 2.08
Coordinate changes in plasma glucose and pancreatic beta-cell function in Latino women at high risk for type 2 diabetes. Diabetes (2006) 2.08
Opportunistic screening for diabetes in routine clinical practice. Diabetes Care (2004) 2.03
Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes?: U.K. prospective diabetes study 61. Diabetes Care (2002) 1.85
A multivariate logistic regression equation to screen for diabetes: development and validation. Diabetes Care (2002) 1.83
Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis. Diabetes Care (1999) 1.83
Performance of recommended screening tests for undiagnosed diabetes and dysglycemia. Diabetes Care (2001) 1.82
Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes. Diabetes Care (2005) 1.81
The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature. Diabetes Care (2005) 1.70
Diabetes Screening in Canada (DIASCAN) Study: prevalence of undiagnosed diabetes and glucose intolerance in family physician offices. Diabetes Care (2001) 1.67
Performance of an NIDDM screening questionnaire based on symptoms and risk factors. Diabetes Care (1997) 1.57
The performance of a risk score as a screening test for undiagnosed hyperglycemia in ethnic minority groups: data from the 1999 health survey for England. Diabetes Care (2004) 1.36
Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study. Diabetes Care (2005) 1.36
Efficient cutoff points for three screening tests for detecting undiagnosed diabetes and pre-diabetes: an economic analysis. Diabetes Care (2005) 1.28
Slow response to loss of glycemic control in type 2 diabetes mellitus. Am J Manag Care (2003) 1.28
The efficacy and cost of alternative strategies for systematic screening for type 2 diabetes in the U.S. population 45-74 years of age. Diabetes Care (2005) 1.28
Costs of screening for pre-diabetes among US adults: a comparison of different screening strategies. Diabetes Care (2003) 1.26
The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care (2003) 1.25
Did publication of a clinical practice guideline recommendation to screen for type 2 diabetes in women with gestational diabetes change practice? Diabetes Care (2003) 1.24
Type 2 diabetes: incremental medical care costs during the 8 years preceding diagnosis. Diabetes Care (2000) 1.20
Screening for diabetes mellitus in adults. The utility of random capillary blood glucose measurements. Diabetes Care (1995) 1.16
Australian Diabetes Screening Study: impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Metabolism (1997) 1.12
Delayed diagnosis of incident type 2 diabetes mellitus in the ARIC study. Am J Manag Care (2006) 1.12
The onset of NIDDM and its relationship to clinical diagnosis in Egyptian adults. Diabet Med (1996) 1.11
Sensitivity and specificity of five screening tests for diabetes in ten countries. Diabetes (1971) 1.10
Impaired fasting glucose and cardiovascular outcomes in postmenopausal women with coronary artery disease. Ann Intern Med (2005) 1.07
New-onset diabetes and risk of all-cause and cardiovascular mortality: the Cardiovascular Health Study. Diabetes Care (2006) 1.04
Treatment escalation and rise in HbA1c following successful initial metformin therapy. Diabetes Care (2006) 1.01
Frequency and determinants of screening for diabetes in the U.S. Diabetes Care (1994) 0.99
Diabetes in urban African-Americans. II. High prevalence of microalbuminuria and nephropathy in African-Americans with diabetes. Diabetes Care (1995) 0.93
Increased utilization of primary care 5 years before diagnosis of type 2 diabetes: a matched cohort study. Diabetes Care (2005) 0.86
High prevalence of albuminuria among African-Americans with short duration of diabetes. Diabetes Care (1998) 0.86
Forgot to fast?: The importance on plasma glucose values. Diabetes Care (2002) 0.76
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med (2007) 25.17
A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science (2007) 18.96
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA (2005) 8.07
Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med (2008) 7.75
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med (2006) 7.32
Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet (2009) 6.83
Diabetes care quality in the Veterans Affairs Health Care System and commercial managed care: the TRIAD study. Ann Intern Med (2004) 6.77
The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet (2008) 6.72
The evolving diabetes burden in the United States. Ann Intern Med (2004) 6.36
Incidence of childhood obesity in the United States. N Engl J Med (2014) 6.07
A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med (2002) 5.64
Comparative effectiveness of revascularization strategies. N Engl J Med (2012) 5.49
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26
Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med (2010) 4.87
Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med (2007) 4.64
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2010) 4.56
A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nat Genet (2005) 4.45
ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents. J Am Coll Cardiol (2012) 4.45
Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis (2002) 4.34
Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. J Am Coll Cardiol (2002) 4.18
Relationship of walking to mortality among US adults with diabetes. Arch Intern Med (2003) 3.95
It's time to overcome clinical inertia. Ann Intern Med (2008) 3.85
Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: a randomized trial. Ann Intern Med (2012) 3.85
The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med (2004) 3.78
Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: a meta-analysis. Diabetes Care (2006) 3.67
Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA (2012) 3.66
Centralized, stepped, patient preference-based treatment for patients with post-acute coronary syndrome depression: CODIACS vanguard randomized controlled trial. JAMA Intern Med (2013) 3.65
Off-pump vs conventional coronary artery bypass grafting: early and 1-year graft patency, cost, and quality-of-life outcomes: a randomized trial. JAMA (2004) 3.48
Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry (2003) 3.48
Diabetes, metformin, and breast cancer in postmenopausal women. J Clin Oncol (2012) 3.47
Monitoring clinical changes in patients with heart failure: a comparison of methods. Am Heart J (2005) 3.26
Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements. Clin Trials (2008) 3.24
Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline. J Am Coll Cardiol (2003) 3.19
Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria. Diabetes Care (2010) 3.12
Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link! J Am Coll Cardiol (2012) 2.93
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. J Am Coll Cardiol (2011) 2.89
Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. J Am Coll Cardiol (2010) 2.86
Cost-effectiveness of eplerenone compared with placebo in patients with myocardial infarction complicated by left ventricular dysfunction and heart failure. Circulation (2005) 2.85
Prevalence of impaired fasting glucose and its relationship with cardiovascular disease risk factors in US adolescents, 1999-2000. Pediatrics (2005) 2.85
Patients with depressive symptoms have lower health status benefits after coronary artery bypass surgery. Circulation (2005) 2.80
Patient adherence improves glycemic control. Diabetes Educ (2005) 2.69
Cardiovascular mortality associated with 5 leading risk factors: national and state preventable fractions estimated from survey data. Ann Intern Med (2015) 2.64
Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT study). Circulation (2012) 2.54
Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry. Circulation (2008) 2.53
Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation (2014) 2.50
Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 2.50
Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coll Cardiol (2010) 2.49
A dynamic Markov model for forecasting diabetes prevalence in the United States through 2050. Health Care Manag Sci (2003) 2.47
Outcomes and long-term survival for patients undergoing mitral valve repair versus replacement: effect of age and concomitant coronary artery bypass grafting. Circulation (2003) 2.45
Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure? J Card Fail (2003) 2.45
Predictors of medication self-management skill in a low-literacy population. J Gen Intern Med (2006) 2.40
Medication use among inner-city patients after hospital discharge: patient-reported barriers and solutions. Mayo Clin Proc (2008) 2.38
An intervention to overcome clinical inertia and improve diabetes mellitus control in a primary care setting: Improving Primary Care of African Americans with Diabetes (IPCAAD) 8. Arch Intern Med (2006) 2.37
Aging, retirement, and changes in physical activity: prospective cohort findings from the GLOBE study. Am J Epidemiol (2007) 2.36
Incident heart failure prediction in the elderly: the health ABC heart failure score. Circ Heart Fail (2008) 2.33
Caloric sweetener consumption and dyslipidemia among US adults. JAMA (2010) 2.30
Long-term follow-up of coronary artery disease presenting in young adults. J Am Coll Cardiol (2003) 2.30
Prevalence and outcomes of same-day discharge after elective percutaneous coronary intervention among older patients. JAMA (2011) 2.29
Health of foreign-born people in the United States: a review. Health Place (2008) 2.29
Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study. Diabetes Care (2003) 2.29
Considerations for diabetes translational research in real-world settings. Diabetes Care (2003) 2.26
Distribution of HbA(1c) levels for children and young adults in the U.S.: Third National Health and Nutrition Examination Survey. Diabetes Care (2002) 2.24
Retracted Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab (2008) 2.21
Association between promoter methylation of serotonin transporter gene and depressive symptoms: a monozygotic twin study. Psychosom Med (2013) 2.19
The Stroke Riskometer(TM) App: validation of a data collection tool and stroke risk predictor. Int J Stroke (2014) 2.18
Thirty-year trends in cardiovascular risk factor levels among US adults with diabetes: National Health and Nutrition Examination Surveys, 1971-2000. Am J Epidemiol (2004) 2.18
Predictors of smoking cessation after a myocardial infarction: the role of institutional smoking cessation programs in improving success. Arch Intern Med (2008) 2.16
Disparities in A1C levels between Hispanic and non-Hispanic white adults with diabetes: a meta-analysis. Diabetes Care (2007) 2.16
Race and ethnic differences in glycemic control among adults with diagnosed diabetes in the United States. Ethn Dis (2007) 2.15
Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050. Arch Ophthalmol (2008) 2.14
Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults. Arch Intern Med (2002) 2.12
Socioeconomic status and diagnosed diabetes incidence. Diabetes Res Clin Pract (2005) 2.08
Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association. Circulation (2011) 2.08
Association of intrauterine exposure to maternal diabetes and obesity with type 2 diabetes in youth: the SEARCH Case-Control Study. Diabetes Care (2008) 2.07